Asselah, J., and C. Sperlich. “Post-Docetaxel Options for Further Survival Benefit in Metastatic Castration-Resistant Prostate Cancer: Questions of Choice”. Canadian Urological Association Journal, vol. 7, no. 1-2-S1, Feb. 2013, pp. S11-S17, doi:10.5489/cuaj.274.